Foscavir and Neupogen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Foscavir (foscarnet sodium) and Neupogen (filgrastim). Common drug interactions include pruritus among females and thrombotic microangiopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Foscavir and Neupogen. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Foscavir?

Foscavir has active ingredients of foscarnet sodium. eHealthMe is studying from 1,631 Foscavir users. Check the latest studies of Foscavir.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.



On Jul, 19, 2026

54 people who take Foscavir and Neupogen together, and have interactions are studied.

Foscavir and Neupogen drug interactions.

What are the common drug interactions of Foscavir and Neupogen, by gender? *:

female:

  1. Pruritus (severe itching of the skin)
  2. Renal disorder (kidney disease)
  3. Respiratory disorder (respiratory disease)
  4. Stenotrophomonas infection
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Blindness
  7. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  8. Viral infection
  9. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  10. Automatism (performance of actions without conscious thought or intention)

male:

  1. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Hypokalaemia (low potassium)
  5. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  6. Hypotension (abnormally low blood pressure)
  7. Multi-organ failure (multisystem organ failure)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Pneumonia
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Foscavir and Neupogen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Blood culture positive
  3. Cachexia (loss of weight)
  4. Pathogen resistance
  5. Pyrexia (fever)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Thrombocytopenia (decrease of platelets in blood)

10-19:

  1. Thrombocytopenia (decrease of platelets in blood)

20-29:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Hypertension (high blood pressure)
  3. Anaemia (lack of blood)
  4. Blood alkaline phosphatase increased
  5. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
  8. Death
  9. Gamma-glutamyltransferase increased
  10. Gastritis (inflammation of stomach)

30-39:

  1. Blood creatine phosphokinase increased
  2. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  3. Cardiac hypertrophy (thickening of the heart muscle)
  4. Confusion
  5. Cystitis haemorrhagic (blood in the urine and painful voiding)
  6. Cytomegalovirus infection
  7. Dementia (madness)
  8. Depressed level of consciousness
  9. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  10. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)

40-49:

  1. Peripheral ischaemia (impaired circulation to an extremity)
  2. Abdominal pain upper
  3. Aortic thrombosis (formation of a blood clot inside aorta)
  4. Pain
  5. Pneumonia
  6. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  7. Arterial embolism limb
  8. Back pain
  9. Blood creatinine increased
  10. Pain in extremity

50-59:

  1. Blood bilirubin increased
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Erosive oesophagitis (acid reflux disease can cause tissue damage in the oesophagus over time)
  4. Fibromyalgia (a long-term condition which causes pain all over the body)
  5. Gastritis (inflammation of stomach)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Multi-organ failure (multisystem organ failure)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Pneumonia
  10. Renal failure (kidney dysfunction)

60+:

  1. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  2. Haemolytic anaemia (anaemia due to haemolysis)
  3. Liver disorder (liver diseases)
  4. Lymphangiopathy (disease of lymph vessels)
  5. Multi-organ failure (multisystem organ failure)
  6. Pyrexia (fever)
  7. Renal disorder (kidney disease)
  8. Respiratory disorder (respiratory disease)
  9. Stenotrophomonas infection
  10. Bone marrow failure

What are the existing conditions these people have? *

  1. Hiv Infection: 5 people, 9.26%
  2. Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 5 people, 9.26%
  3. Stomatitis (inflammation of mucous membrane of mouth): 4 people, 7.41%
  4. Cytomegalovirus Infection: 4 people, 7.41%
  5. Oral Candidiasis (fungal infection of mouth): 3 people, 5.56%
  6. Leukopenia (less number of white blood cells in blood): 3 people, 5.56%
  7. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Foscavir and Neupogen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Foscavir and Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Foscavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Foscavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupogen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on foscarnet sodium and filgrastim (the active ingredients of Foscavir and Neupogen, respectively), and Foscavir and Neupogen (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: